Echo Therapeutics Bullish on Recent News (OTC:ECTE)
Jay Garcilazo (November 20th, 2009) Writes:
MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell on heavy buying pressure. The excitement was due to the announcement on positive results of a clinical study testing symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes. Despite the fact that there has been a recent common shares financing scheduled, companies usually take their time and let the price consolidate before engaging in these activities, thus a short-term buy could be a smart investment. Towards the end of this alert a technical analysis will also be issued.
According to the ADA, the cost of diabetes care in the United States in
...AzoneTS™ Pipeline, Biotech, comfortable-to-wear continuous glucose monitoring device, Diabetes, diabetes care;, drug delivery, Echo Therapeutics Inc., FavStocks, Fda, Investing Lessons, MivInvestments Inc., Prelude SkinPrep System, skin ablation control technology, Stocks to Watch, Symphony tCGM System, Symphony™ tCGM System, Symphony™ tCGM System Pipeline, transdermal biosensor technologies, United States, USD, wireless transmission


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)









